Charles River Laboratories | CRL - 销售收入



金融业
股票价格
USD
资产
USD 7.53B
现金及等价物
USD 192.03M
销售成本
USD 655.29M
流动资产
USD 1.53B
流动负债
USD 1.13B
债务
USD 3.06B
EBIT
USD 119.89M
EBITDA
USD 272.95M
员工
18.6K
EPS每股收益
USD 3.02
股本和储备
USD 2.84B
销售毛利
USD 348.79M
债务利息支出
USD 30.34M
利息收入
USD -0.03
贷款资金
USD 2.62B
市值
USD 14.86B
净收入
USD -1.48M
营业费用
USD 2.84B
营业利润
USD 119.89M
普通股股本
USD 47.73M
PE价格收益
58.27
税前利润
USD -29.94M
销售收入
USD 1B
销售和管理费用
USD 228.9M
股票
USD 346.26M
贸易债权人
USD 140.98M
应收帐款人
USD 711.76M


销售 更改 日
Agilent USD 1.88B 43M 2026-06
Align Technology USD 1.06B 20M 2026-06
Bio-Rad Laboratories USD 651M 58.9M 2026-06
Bruker USD 838.5M 15.1M 2026-06
Cardinal Health USD 63.7B 2.8B 2026-06
Charles River Laboratories USD 1000M 4.2M 2026-06
Cigna USD 71.7B 3.18B 2026-06
Concord Medical Services Hldg CNY 259.9M 59.28M 2025-12
CVS Health USD 106.1B 5.7B 2026-06
Danaher USD 6.3B 350M 2026-06
Dentsply International USD 898M 18M 2026-06
Elevance Health USD 49.8B 300M 2026-06
Humana USD 40.89B 1.24B 2026-06
Illumina USD 1.16B 70M 2026-06
Incyte USD 1.67B 400M 2026-06
Intrexon USD 717K 511K 2024-06
IQVIA Holdings USD 4.37B 220M 2026-06
Laboratory Of America USD 3.73B 190M 2026-06
Lakefront Biotherapeutics EUR 12.11M 5.61M 2026-06
Lonza CHF 3.58B 63M 2025-06
McKesson USD 105.38B 13.08B 2026-06
Merck EUR 5.43B 300M 2026-06
Mettler Toledo International USD 1.03B 82.87M 2026-06
Novartis USD 14.41B 1.3B 2026-06
Pfizer USD 15.03B 530M 2026-06
Quest Diagnostics USD 3.04B 140M 2026-06
Revvity USD 729.68M 18.68M 2026-06
Thermo Fisher Scientific USD 11.99B 980M 2026-06
United Therapeutics USD 783.3M 1.8M 2026-06
UnitedHealth USD 112B 300M 2026-06
Veradigm USD 142.52M 9.38M 2022-12
Waters USD 1.64B 370M 2026-06
West Pharmaceutical Services USD 872.3M 27.4M 2026-06